Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 8/20 | 0.37 |
| ▸ | FNTB | P49356 | 8/20 | 0.37 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.35 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.32 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ranelic Acid SCHEMBL1289746 | 1.00 | FNTA (0.37) | FNTAFNTBGRIA4GRIA2PLA2G1B | |
| Ranelic Acid SCHEMBL8641592 | 0.98 | FNTA (0.36) | FNTAFNTBGRIA4GRIA2PLA2G1B | |
| Ranelic Acid SCHEMBL2227556 | 0.98 | FNTA (0.36) | FNTAFNTBGRIA4GRIA2PLA2G1B | |
| Ranelic Acid SCHEMBL2549310 | 0.98 | FNTA (0.36) | FNTAFNTBGRIA4GRIA2PLA2G1B | |
| Ranelic Acid SCHEMBL15875995 | 0.98 | FNTA (0.36) | FNTAFNTBGRIA4GRIA2PLA2G1B | |
| SCHEMBL14457745 | 0.93 | GRIA4 (0.37) | FNTAFNTBGRIA4GRIA2PLA2G1B | |
| SCHEMBL14473856 | 0.91 | FNTA (0.33) | FNTAFNTBGRIA4GRIA2 | |
| Ranelic Acid SCHEMBL2511382 | 0.89 | FNTA (0.34) | FNTAFNTBGRIA4GRIA2 | |
| Ranelic Acid SCHEMBL15875990 | 0.87 | — | — | |
| Ranelic Acid SCHEMBL8641585 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 485 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117051245-A | Method for recycling valuable elements in metallurgical waste residues | 西安建筑科技大学 | 2023-11-14 | — | — | CN | claimed |
| EP-2756841-B1 | Pharmaceutical compositions comprising an acid salt | GALENICUM HEALTH SL (ES) | 2015-05-13 | — | — | EP | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20130310573-A1 | PROCESS FOR THE PREPARATION OF STRONTIUM RANELATE | DIVI'S LABORATORIES LIMITED (IN) | 2013-11-21 | — | — | US | claimed |
| US-8569514-B1 | Process for the preparation of strontium ranelate | Divi's Laboratories, Ltd. (IN) | 2013-10-29 | — | — | US | claimed |
| WO-2013113319-A1 | PROCESS FOR THE PREPARATION OF STRONTIUM RANELATE, INTERMEDIATE OR HYDRATES THEREOF | PHARMATHEN S.A. (GR) | 2013-08-08 | — | — | WO | claimed |
| EP-2542546-A1 | PROCESS FOR THE PREPARATION OF A POLYMORPH OF STRONTIUM RANELATE | Chemelectiva Srl. (IT) | 2013-01-09 | — | — | EP | claimed |
| EP-2523947-A1 | PROCESS FOR THE PREPARATION OF STRONTIUM RANELATE | Richter Gedeon Nyrt. (HU) | 2012-11-21 | — | — | EP | claimed |
| US-8268352-B2 | Modified release composition for highly soluble drugs | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-18 | — | — | US | claimed |
| US-8263125-B2 | Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-11 | — | — | US | claimed |
| WO-2005108339-A2 | HIGH YIELD AND RAPID SYNTHESES METHODS FOR PRODUCING METALLO-ORGANIC SALTS | OSTEOLOGIX A/S (DK) | 2005-11-17 | — | — | WO | claimed |
| EP-1403264-B1 | Process for the industrial synthesis of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxydimethylester | SERVIER LAB (FR) | 2004-12-29 | — | — | EP | claimed |
| WO-2004098618-A2 | STRONTIUM COMBINATIONS FOR PROPHYLAXIS/TREATMENT OF CARTILAGE AND/OR BONE CONDITIONS | OSTEOLOGIX A/S (DK) | 2004-11-18 | — | — | WO | claimed |
| WO-2004098617-A2 | CONTROLLED RELEASE COMPOSITION CONTAINING A STRONTIUM SALT | OSTEOLOGIX A/S (DK) | 2004-11-18 | — | — | WO | claimed |
| US-20040059134-A1 | Process for the industrial synthesis of tetraesters of 5-[BIS(CARBOXYMETHYL)AMINO]-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates | LES LABORATOIRES SERVIER (FR) | 2004-03-25 | — | — | US | claimed |
| US-20040059135-A1 | Process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates | LES LABORATOIRES SERVIER (FR) | 2004-03-25 | — | — | US | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| EP-0813869-B1 | Use of strontium salts for the treatment of arthritis | SERVIER LAB (FR) | 2003-03-05 | — | — | EP | claimed |
| EP-0415850-B1 | Bivalent metal salts of 2-N,N-di(carboxymethyl)amino,3-cyano,4-carboxymethyl,5-carboxy-thiophene-acid, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1994-01-12 | — | — | EP | claimed |
| US-5128367-A | Osteoporosis | ADIR ET COMPAGNIE (FR) | 1992-07-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040059135-A1 | Process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates | CA7, CA2, SLC38A7 | FNTA 2847/4885FNTB 3509/4885GRIA4 1008/4885 |
| US-20130310573-A1 | PROCESS FOR THE PREPARATION OF STRONTIUM RANELATE | HDHD5, HPSE, DHX35 | FNTA 4515/4885FNTB 4847/4885GRIA4 1962/4885 |
| US-20040059134-A1 | Process for the industrial synthesis of tetraesters of 5-[BIS(CARBOXYMETHYL)AMINO]-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates | CA7, SLC6A6, CA6 | FNTA 3614/4885FNTB 3445/4885GRIA4 1280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.